DocGo (NASDAQ:DCGO), which combined with Motion in November 2021, announced that it will redeem all of its outstanding warrants at 5 pm ET September 16 at a redemption price of $0.10 per warrant.
Holders may also swap their warrants on a cashless basis for 0.2233 of a common share as a part of the exchange. The company is allowed to launch this call because the last share price of its shares was $10 or above on August 12.
In fact, the company has been on a tear, rising +31.3% over the past month. It closed yesterday at $10.20 on the backs of three successive profitable quarters as a public company. DocGo most recently beat its second quarter revenue estimates by about 10% and upped its revenue guidance for the year.
Holders may also exercise their warrants at $11.50 per share until September 16.
DocGo provides “last-mile” medical services such as medical transportation and telehealth, and it has been active in providing mobile COVID-19 stations throughout the country. This morning, it also announced that it has been contracted to provide mobile health services to Medicare-eligible patients covered by New Jersey’s largest health insurer, Horizon.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...